Current options for treatment of chronic coronary artery disease

Sotirios N Prapas1, Kosmas Tsakiridis1, Paul Zarogoulidis1

  • 11 Cardiac Surgery Department, Director of "Henry Dunant" Hospital, Athens, Greece ; 2 Cardiothoracic Surgery Department, "Saint" Luke Private Hospital, Thessaloniki, Panorama, Greece ; 3 Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece ; 4 Surgery Department (NHS), University General Hospital of Alexandroupolis, Alexandroupolis, Greece ; 5 Internal Medicine Department, "Theageneio" Anticancer Hospital, Thessaloniki, Greece ; 6 Pathology Department, "G. Papanikolaou" General Hospital, Thessaloniki, Greece.

Insights

For chronic coronary artery disease (CAD), revascularization is beneficial only if ischemia is proven. Treatment decisions for CAD patients hinge on symptoms, ischemia evidence, and coronary anatomy complexity.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Chronic coronary artery disease (CAD) management involves complex treatment decisions.
  • Key considerations include revascularization appropriateness and method selection.
  • Patient symptoms, ischemia evidence, and coronary anatomy guide these choices.

Purpose of the Study:

  • To discuss primary issues in treating chronic CAD patients.
  • To outline criteria for revascularization appropriateness and method selection.
  • To present current treatment options for CAD.

Main Methods:

  • Review of clinical criteria for revascularization decisions.
  • Evaluation of factors influencing prognosis (left ventricular function, stenosis extent, ischemic burden).
  • Comparison of surgical versus interventional approaches.

Main Results:

  • Revascularization offers no benefit for patients with symptoms but no ischemia.
  • Proven ischemia indicates benefit from revascularization.
  • Prognosis is determined by left ventricular function, number of stenosed arteries, and ischemic burden.

Conclusions:

  • Treatment decisions for chronic CAD must balance symptom persistence, ischemia, and anatomical complexity.
  • Revascularization is indicated when ischemia is present and symptoms persist despite medical therapy.
  • The choice between surgical and interventional revascularization depends on individual patient factors and current treatment options.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890